1. 2022-LBA-607-ESGO How long do our patients stay fasting? a multicentric prospective survey on the perioperative fasting in 924 Patients conducted by the JAGO study group. (27th October 2022) Authors: Beck, Maximilian Heinz; Balci-Hakimeh, Derya; Scheuerecker, Florian; Wallach, Charlotte; Wißbrock, Hannah; Blohmer, Jens-Uwe; Sehouli, Jalid; Pietzner, Klaus Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1043-ESGO CT-guided percutenous radiologic gastrostomy in heavily pretreated patients with late stage ovarian cancer: -the charité experiences-. (20th October 2022) Authors: Canaz, Emel; Auer, Timo Alexander; Gebauer, Bernhard; Sehouli, Jalid Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1057-ESGO Outcomes of gynaecological cancer surgery during the covid-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study. (20th October 2022) Authors: Fotopoulou, Christina; Khan, Tabassum; Bracinik, Juraj; Glasbey, James; Abu-Rustum, Nadeem; Chiva, Luis; Fagotti, Anna; Fujiwara, Kaiichi; Ghebre, Rahel; Gutelkin, Murat; Konney, Thomas; Ng, Joseph; Pareja, Rene; Seenivasagam, Rajkumar; Sehouli, Jalid; Surappa, Shylasree; Bhangu, Aneel; Leung, El... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-1089-ESGO Opportunistic salpingectomy (OS) for prevention of ovarian cancer has become a de facto standard in Germany. (20th October 2022) Authors: Kather, Angela; Vorwergk, Julia; Cruz, Jorge Jimenez; Mothes, Anke R; Beteta, Carmen C; Keller, Maren; Pölcher, Martin; Mustea, Alexander; Sehouli, Jalid; Runnebaum, Ingo B Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-1093-ESGO Validation of self-sampling use for a multiplexed biomarker assay for HPV and dysplasia detection. (20th October 2022) Authors: Skof, Anna Sophie; Payrich, Eva-Maria; Struck, Maja; Thies, Sarah; Schreckenberger, Carola; Sehouli, Jalid; Kaufmann, Andreas M Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-1094-ESGO Implementation of a tri-modal prehabilitation intervention – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients. (20th October 2022) Authors: Inci-Turan, Melisa Guelhan; Lee, Marlene; Rattunde, Magdalena; Schneider, Stephanie; Schnura, Eva; Klews, Julia; Bergjan, Manuela; Algharably, Engi; Sehouli, Adak Pirmorady; Reißhauer, Anett; Knappe-Drzikova, Barbora; Zwanzleitner, Lena; Roll, Stephanie; Reinhold, Thomas; Harter, Philipp; Sehouli... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2022-RA-1116-ESGO Barriers in the cervical cancer screening program and how self-sampling for HPV-testing is experienced as a solution to them. (20th October 2022) Authors: Payrich, Eva Maria; Skof, Anna Sophie; Struck, Maja; Thies, Sarah; Schreckenberger, Carola; Sehouli, Jalid; Kaufmann, Andreas Martin Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2022-RA-1154-ESGO Ovarian cancer management. Who cares for the Patient? A single case observational study. (20th October 2022) Authors: Krankenberg, David Johannes; Pietzner, Klaus; Muallem, Mustafa Zelal; Lee, Marlene; Sehouli, Jalid Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2022-RA-1192-ESGO NOGGO ov44 – PERCEPTION What is the role of immunotherapy in low grade ovarian cancer? A NOGGO phase II trial of pembrolizumab in combination with chemotherapy in recurrent low-grade serous ovarian cancer. (20th October 2022) Authors: Grabowski, Jacek; Pietzke, Lea-Jean; Zocholl, Dario; Harter, Philipp; Heitz, Florian; Welz, Julia; Kaiser, Sabrina; Arndt, Tjadina; Chekerov, Radoslav; Sehouli, Jalid Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 2022-RA-1256-ESGO First experiences of implementing 'enhanced recovery after surgery' (ERAS) at two German ESGO centers of excellence – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients. (20th October 2022) Authors: Inci-Turan, Melisa Guelhan; Schneider, Stephanie; Schnura, Eva; Lee, Marlene; Lauseker, Marcus; Klews, Julia; Lohrmann, Renée; Baack, Angelika; Meinert, Fabian; Zwanzleitner, Lena; Roll, Stephanie; Reinhold, Thomas; Harter, Philipp; Sehouli, Jalid Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗